miRagen Therapeutics Inc (MGEN)
Stock chart
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 2024-09-27 | PP Planned purchase |
Chief Operating Officer Officer |
5,000
+500.0%
23.41USD 117,050 |
5,000 +500.0% | 23.41 | USD 117,050 | |
| 2024-09-30 | 2024-09-27 | B Purchase |
President and CEO Executive Director |
21,400
+inf%
23.33USD 499,262 |
21,400 +inf% | 23.33 | USD 499,262 | |
| 2024-09-17 | 2024-09-13 | B Purchase |
Fairmount Funds Management LLC Non-Executive Director Large shareholder |
1,600,000
+86.7%
18.75USD 30,000,000 |
1,600,000 +86.7% | 18.75 | USD 30,000,000 | |
| 2024-01-24 | 2024-01-22 | B Purchase |
Fairmount Funds Management LLC See Remarks Non-Executive Director Large shareholder |
476,190
+34.9%
21.00USD 9,999,990 |
476,190 +34.9% | 21.00 | USD 9,999,990 | |
| 2023-06-20 | 2023-06-16 | S Sale |
Chief Legal Officer Officer |
27
-0.1%
28.35USD 765 |
27 -0.1% | 28.35 | USD 765 | |
| 2023-06-20 | 2023-06-15 | PS Planned sale |
Chief Legal Officer Officer |
2,269
-7.0%
28.02USD 63,577 |
2,269 -7.0% | 28.02 | USD 63,577 | |
| 2023-06-06 | 2023-06-06 | S Sale |
Chief Legal Officer Officer |
5,126
-14.6%
25.02USD 128,253 |
5,126 -14.6% | 25.02 | USD 128,253 | |
| 2023-06-06 | 2023-06-05 | S Sale |
Chief Legal Officer Officer |
499
-1.6%
25.03USD 12,490 |
499 -1.6% | 25.03 | USD 12,490 | |
| 2023-06-06 | 2023-06-02 | PS Planned sale |
Chief Legal Officer Officer |
1,875
-5.9%
24.21USD 45,394 |
1,875 -5.9% | 24.21 | USD 45,394 | |
| 2023-04-12 | 2023-04-12 | B Purchase |
Chief Executive Officer Executive Director |
4,000
+1.6%
25.37USD 101,479 |
4,000 +1.6% | 25.37 | USD 101,479 | |
| 2023-03-13 | 2023-03-13 | B Purchase |
Chief Executive Officer Executive Director |
5,500
+2.2%
29.15USD 160,324 |
5,500 +2.2% | 29.15 | USD 160,324 | |
| 2023-03-10 | 2023-03-09 | PS Planned sale |
General Counsel and Secretary Officer |
29,971
-100.0%
29.07USD 871,257 |
29,971 -100.0% | 29.07 | USD 871,257 | |
| 2023-02-03 | 2023-02-02 | PS Planned sale |
Chief Executive Officer Executive Director |
50,000
-10.4%
36.80USD 1,840,000 |
50,000 -10.4% | 36.80 | USD 1,840,000 | |
| 2023-01-25 | 2023-01-23 | PS Planned sale |
General Counsel and Secretary Officer |
6,843
-100.0%
35.66USD 244,021 |
6,843 -100.0% | 35.66 | USD 244,021 | |
| 2023-01-18 | 2023-01-17 | PS Planned sale |
Chief Medical Officer Officer |
24,853
-100.0%
37.21USD 924,780 |
24,853 -100.0% | 37.21 | USD 924,780 | |
| 2023-01-18 | 2023-01-13 | PS Planned sale |
Chief Medical Officer Officer |
4,147
-100.0%
37.01USD 153,480 |
4,147 -100.0% | 37.01 | USD 153,480 | |
| 2023-01-11 | 2023-01-10 | PS Planned sale |
Chief Medical Officer Officer |
47,377
-100.0%
35.30USD 1,672,408 |
47,377 -100.0% | 35.30 | USD 1,672,408 | |
| 2023-01-11 | 2023-01-09 | PS Planned sale |
Chief Medical Officer Officer |
12,623
-100.0%
33.04USD 417,064 |
12,623 -100.0% | 33.04 | USD 417,064 | |
| 2022-12-22 | 2022-12-21 | PS Planned sale |
General Counsel and Secretary Officer |
16,326
-100.0%
29.19USD 476,556 |
16,326 -100.0% | 29.19 | USD 476,556 | |
| 2022-12-22 | 2022-12-20 | PS Planned sale |
General Counsel and Secretary Officer |
600
-100.0%
28.07USD 16,842 |
600 -100.0% | 28.07 | USD 16,842 | |
| 2022-12-19 | 2022-12-16 | PS Planned sale |
General Counsel and Secretary Officer |
1,297
-100.0%
28.44USD 36,887 |
1,297 -100.0% | 28.44 | USD 36,887 | |
| 2022-12-19 | 2022-12-15 | PS Planned sale |
General Counsel and Secretary Officer |
300
-100.0%
28.08USD 8,424 |
300 -100.0% | 28.08 | USD 8,424 | |
| 2022-12-14 | 2022-12-14 | PS Planned sale |
General Counsel and Secretary Officer |
15,656
-100.0%
28.12USD 440,247 |
15,656 -100.0% | 28.12 | USD 440,247 | |
| 2022-12-14 | 2022-12-12 | PS Planned sale |
General Counsel and Secretary Officer |
600
-100.0%
28.05USD 16,830 |
600 -100.0% | 28.05 | USD 16,830 | |
| 2022-11-16 | 2022-11-15 | PS Planned sale |
General Counsel and Secretary Officer |
8,125
-100.0%
22.05USD 179,156 |
8,125 -100.0% | 22.05 | USD 179,156 | |
| 2022-08-19 | 2022-08-17 | B Purchase |
Fairmount Funds Management LLC Non-Executive Director Large shareholder |
425,531
+45.4%
23.50USD 9,999,979 |
425,531 +45.4% | 23.50 | USD 9,999,979 | |
| 2022-06-02 | 2022-06-01 | PS Planned sale |
Chief Executive Officer Executive Director |
30,000
-5.9%
12.20USD 366,000 |
30,000 -5.9% | 12.20 | USD 366,000 | |
| 2022-05-04 | 2022-05-02 | PS Planned sale |
Chief Executive Officer Executive Director |
30,000
-5.5%
13.04USD 391,200 |
30,000 -5.5% | 13.04 | USD 391,200 | |
| 2022-04-05 | 2022-04-04 | PS Planned sale |
Chief Executive Officer Executive Director |
3,600
-0.7%
18.93USD 68,148 |
3,600 -0.7% | 18.93 | USD 68,148 | |
| 2022-04-05 | 2022-04-01 | PS Planned sale |
Chief Executive Officer Executive Director |
26,400
-4.6%
18.92USD 499,488 |
26,400 -4.6% | 18.92 | USD 499,488 | |
| 2022-03-03 | 2022-03-02 | PS Planned sale |
Chief Executive Officer Executive Director |
11,106
-1.9%
17.36USD 192,800 |
11,106 -1.9% | 17.36 | USD 192,800 | |
| 2022-03-03 | 2022-03-01 | PS Planned sale |
Chief Executive Officer Executive Director |
18,894
-3.1%
17.82USD 336,691 |
18,894 -3.1% | 17.82 | USD 336,691 | |
| 2022-02-03 | 2022-02-03 | PS Planned sale |
Chief Executive Officer Executive Director |
909
-0.2%
19.16USD 17,416 |
909 -0.2% | 19.16 | USD 17,416 | |
| 2022-02-03 | 2022-02-02 | PS Planned sale |
Chief Executive Officer Executive Director |
12,340
-2.0%
18.47USD 227,920 |
12,340 -2.0% | 18.47 | USD 227,920 | |
| 2022-02-03 | 2022-02-01 | PS Planned sale |
Chief Executive Officer Executive Director |
16,751
-2.7%
19.55USD 327,482 |
16,751 -2.7% | 19.55 | USD 327,482 | |
| 2021-09-28 | 2021-09-23 | B Purchase |
Frazier Life Sciences Public Fund, L.P. Large shareholder |
200,000
+15.3%
11.00USD 2,200,000 |
200,000 +15.3% | 11.00 | USD 2,200,000 | |
| 2020-11-16 | 2020-11-13 | B Purchase | Large shareholder |
126,667
+29.9%
14.84USD 1,879,599 |
126,667 +29.9% | 14.84 | USD 1,879,599 | |
| 2020-11-16 | 2020-11-09 | B Purchase | Large shareholder |
100,000
+1.6%
1.16USD 116,410 |
100,000 +1.6% | 1.16 | USD 116,410 | |
| 2020-11-16 | 2020-11-09 | B Purchase | Large shareholder |
250,000
+4.2%
1.10USD 274,475 |
250,000 +4.2% | 1.10 | USD 274,475 | |
| 2018-10-12 | 2018-10-11 | B Purchase |
Hughes Thomas E. Non-Executive Director |
10,000
+353.7%
4.77USD 47,697 |
10,000 +353.7% | 4.77 | USD 47,697 | |
| 2018-02-13 | 2018-02-13 | B Purchase |
Levy Adam Scott Chief Business Officer Officer |
9,090
+626.9%
5.50USD 49,995 |
9,090 +626.9% | 5.50 | USD 49,995 | |
| 2018-02-13 | 2018-02-13 | B Purchase |
Booth Bruce Non-Executive Director |
545,454
+67.7%
5.50USD 2,999,997 |
545,454 +67.7% | 5.50 | USD 2,999,997 | |
| 2017-12-22 | 2017-12-20 | S Sale |
Hughes Thomas E. |
12,000
-80.9%
8.00USD 96,000 |
12,000 -80.9% | 8.00 | USD 96,000 | |
| 2017-06-23 | 2017-06-22 | B Purchase |
Levy Adam Scott Chief Business Officer |
200
+inf%
7.55USD 1,510 |
200 +inf% | 7.55 | USD 1,510 | |
| 2017-03-13 | 2017-03-10 | S Sale |
LEFKOFF KYLE Non-Executive Director |
3,300
-0.7%
14.31USD 47,229 |
3,300 -0.7% | 14.31 | USD 47,229 | |
| 2017-03-13 | 2017-03-09 | S Sale |
LEFKOFF KYLE Non-Executive Director |
2,500
-0.5%
14.38USD 35,962 |
2,500 -0.5% | 14.38 | USD 35,962 | |
| 2017-03-08 | 2017-03-08 | S Sale |
LEFKOFF KYLE Non-Executive Director |
5,000
-1.1%
14.70USD 73,514 |
5,000 -1.1% | 14.70 | USD 73,514 | |
| 2017-03-08 | 2017-03-06 | S Sale |
LEFKOFF KYLE Non-Executive Director |
608
-0.1%
16.24USD 9,874 |
608 -0.1% | 16.24 | USD 9,874 | |
| 2017-03-08 | 2017-03-06 | S Sale |
LEFKOFF KYLE Non-Executive Director |
9,392
-1.9%
15.71USD 147,590 |
9,392 -1.9% | 15.71 | USD 147,590 | |
| 2017-02-28 | 2017-02-28 | S Sale |
LEFKOFF KYLE Non-Executive Director |
2,258
-0.5%
13.54USD 30,580 |
2,258 -0.5% | 13.54 | USD 30,580 | |
| 2017-02-28 | 2017-02-27 | S Sale |
LEFKOFF KYLE Non-Executive Director |
1,500
-0.3%
13.79USD 20,687 |
1,500 -0.3% | 13.79 | USD 20,687 | |
| 2017-02-28 | 2017-02-24 | S Sale |
LEFKOFF KYLE Non-Executive Director |
6,500
-1.3%
14.04USD 91,252 |
6,500 -1.3% | 14.04 | USD 91,252 | |
| 2017-02-24 | 2017-02-23 | S Sale |
LEFKOFF KYLE Non-Executive Director |
1,800
-0.4%
13.65USD 24,566 |
1,800 -0.4% | 13.65 | USD 24,566 | |
| 2017-02-24 | 2017-02-22 | S Sale |
LEFKOFF KYLE Non-Executive Director |
4,102
-0.8%
14.36USD 58,886 |
4,102 -0.8% | 14.36 | USD 58,886 | |
| 2015-11-23 | 2015-11-20 | B Purchase |
Riccitelli Samuel D President & CEO Executive Director |
7,000
+2.1%
0.80USD 5,600 |
7,000 +2.1% | 0.80 | USD 5,600 | |
| 2015-11-23 | 2015-11-19 | B Purchase |
Riccitelli Samuel D President & CEO Executive Director |
7,000
+2.1%
0.78USD 5,460 |
7,000 +2.1% | 0.78 | USD 5,460 |